Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia

Sponsor
Kuala Lumpur General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02983344
Collaborator
Universiti Kebangsaan Malaysia Medical Centre (Other)
24
1
2
20
1.2

Study Details

Study Description

Brief Summary

This study is performed to determine the efficacy of ultrasound-guided fascia iliaca compartment block during positioning for spinal anaesthesia in patient undergoing repair of proximal femur fracture surgery comparing with intravenous fentanyl.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

This a prospective, single-blind, randomized control study that compare the efficacy of ultrasound-guided fascia iliaca compartment block with intravenous fentanyl in positioning patient with femur fracture for spinal anaesthesia.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia : Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Fentanyl
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: fascia iliaca compartment block

Patient will receive 40ml of ropivacaine 0.375% at the fascia iliaca compartment under the guidance of ultrasound. It will be given 20 minutes before patient is positioned for spinal anaesthesia

Drug: Ropivacaine
Fascia iliaca compartment block using ropivacaine

Device: Ultrasound
Ultrasound-guided fascia iliaca compartment block

Active Comparator: intravenous fentanyl

Patient will receive 0.5 mcg/kg of intravenous fentanyl. It will be given 5 minutes before patient is positioned for spinal anaesthesia

Drug: Fentanyl
Intravenous fentanyl

Outcome Measures

Primary Outcome Measures

  1. Pain score during positioning [Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)]

    Pain score is assessed using Visual Analogue Scale (VAS) score

Secondary Outcome Measures

  1. Ease of positioning for spinal anaesthesia [Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)]

    It will be characterized as 'very difficult', 'difficult', 'easy' and 'very easy'

  2. Patient satisfaction [24 hours after intervention]

    Patient will be asked whether they will choose the same analgesic technique in the event of future operation : 'yes' or 'no'.

  3. Adverse effects [Up to 24 hours of intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anaesthesiologists (ASA) score I and II

  • Elective surgery of repair of unilateral, single femoral fracture under spinal anaesthesia performed in General Operation Theatre, Hospital Kuala Lumpur. The fracture may involve femoral neck or femoral shaft.

Exclusion Criteria:
  • Patient with contraindication for spinal anaesthesia

  • Known hypersensitivity or contraindication to medication used in this study

  • Morbid obesity (body mass index (BMI) > 35 kg/m2)

  • Infection at the intended site of administration of fascia iliaca compartment block

  • Patient with impaired cognitive function

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kuala Lumpur General Hospital Kuala Lumpur Wilayah Persekutuan Malaysia 50586

Sponsors and Collaborators

  • Kuala Lumpur General Hospital
  • Universiti Kebangsaan Malaysia Medical Centre

Investigators

  • Study Chair: Raha Abdul Rahman, MBBS, Universiti Kebangsaan Malaysia Medical Centre
  • Principal Investigator: Azrin Mohd Azidin, MBBS, Kuala Lumpur General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Aida Mastura Mohd Shah, Principle Investigator, Kuala Lumpur General Hospital
ClinicalTrials.gov Identifier:
NCT02983344
Other Study ID Numbers:
  • NMRR-15-757-25608
First Posted:
Dec 6, 2016
Last Update Posted:
Sep 6, 2017
Last Verified:
Sep 1, 2017
Keywords provided by Dr Aida Mastura Mohd Shah, Principle Investigator, Kuala Lumpur General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 6, 2017